Clinical Trials in Bury St Edmunds, United Kingdom
8 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled452 locationsNCT06531824
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
Phase 2Phase 3
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Motor Neuron Disease / Amyotrophic Lateral Sclerosis
University of Edinburgh1,150 enrolled22 locationsNCT04302870
Recruiting
Phase 3
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Idiopathic Pulmonary Fibrosis
Norfolk and Norwich University Hospitals NHS Foundation Trust298 enrolled57 locationsNCT04965298
Recruiting
Not Applicable
Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
Kidney Failure, ChronicHyperphosphatemia
The University of Queensland3,600 enrolled115 locationsNCT03573089
Recruiting
Phase 2
TherApeutics in Early ProState Cancer (TAPS02)
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust90 enrolled6 locationsNCT05191680
Recruiting
Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
Giant Cell ArteritisPolymyalgia Rheumatica
University of Leeds4,500 enrolled76 locationsNCT04102930
Recruiting
Not Applicable
GEKO Venous Thromboembolism Prevention Study
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+1 more
Firstkind Ltd1,200 enrolled18 locationsNCT05476913
Recruiting
Phase 3
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
Prostate Cancer
Institute of Cancer Research, United Kingdom1,128 enrolled42 locationsNCT05613023
Recruiting
Phase 2Phase 3
Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust780 enrolled30 locationsNCT03150576